Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea for Nefecon for the Treatment of Primary IgA Nephropathy ...Middle East

-- Taiwan Food and Drug Administration grants Accelerated Approval Designation (AAD) to Nefecon -- -- Ministry of Food and Drug Safety in South Korea grants ODD to Nefecon -- -- Nefecon is a first-in-disease treatment for IgAN patients and has been approved in U.S. and E.U. -- SHANGHAI,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea for Nefecon for the Treatment of Primary IgA Nephropathy )

Also on site :

• Greece probes Azerbaijani arrested for espionage for links to Iran
• Russia ready to help Iran: Kremlin spokesman
• Music Icon's Rarely Seen Daughter, 77, Photographed in Los Angeles